Pfizer standaone Q3 net at Rs 18 cr

Net sales at Rs 465 cr; third quarter results not comparable due to scheme of amalgamation with Wyeth

Press Trust of India New Delhi
Last Updated : Feb 14 2015 | 9:57 PM IST
Drug firm Pfizer on Saturday reported a stand-alone net profit of Rs 18 crore for the quarter ended December.

It had posted a net profit of Rs 47.6 crore a year ago, Pfizer said in a filing to the BSE.

Net sales during the quarter were Rs 464.6 crore. It was Rs 248 crore a year ago.

Pfizer said the quarter’s results were not comparable because of a scheme of amalgamation between the company and Wyeth.

"The results for the current quarter and nine months are not comparable," it said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 14 2015 | 9:31 PM IST

Next Story